A Study to Evaluate Safety and Efficacy of PHX1149T in Subjects With Type 2 Diabetes Mellitus
Status:
Unknown status
Trial end date:
2008-02-01
Target enrollment:
Participant gender:
Summary
This study is to test the efficacy and safety of PHX1149T in combination with metformin, a
glitazone, or metformin and a glitazone in subjects with Type 2 diabetes for 12 weeks. After
completing the 12 week double blind part of the study, subjects can enter an open label
extension study